This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
We are delighted to announce that the deadline to apply as an ETAHP board member has been extended: the new deadline is 4 December 2022. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. In addition, you may nominate yourself or a colleague. The new ETAHP Board Members will hold office for four
The European Transplant Allied Healthcare Professionals (ETAHP) – would like to announce a call for nominations for two new Board members. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new ETAHP Board Members will hold office for 4 years (2022-2026), starting December 2022. In
We would like to announce a call for nominations for four new Board members. ESOT/VCA affiliates are eligible to submit their application for the positions. The intention of the ESOT VCA Section is to foster the scientific and clinical development of Vascularized Composite Allotransplantation in Europe and to serve as a platform for scientists and
An assessment of the impact of COVID-19 on transplantation practice, one year from the start of the pandemic.
On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of additional European national authorities and expect to finalise agreement with participating countries by the end of April 2021. In addition, ESOT is establishing contacts with non-European countries and registries. read more
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the World’s leading transplant experts. Read the TLJ20Report for the